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1. Introduction  
Traditionally, psychiatric research considers alcohol as a harmful substance focusing 
mainly on the extreme of excessive alcohol consumption. From a public health 
perspective, however, evaluating the effects of abstinence and moderate use of alcohol are 
equally important because they are much more common compared to alcohol dependence 
or abuse, while alcohol is incorporated in everyday nutrition of several cultures e.g. 
Mediterranean and South-American cultures (Room and Makela, 2000).  
Several cross-sectional (Bellos et al. 2013; Caldwell et al. 2002; Kirchner et al. 2007; 
O’Donnell et al. 2006; Power et al. 1998; Skogen et al. 2009) and longitudinal studies (Bell 
and Britton, 2015; Bell and Britton, 2014; Cougle et al. 2015; Gea et al. 2013, Gea et al. 
2012, Tait et al. 2012) that have examined the full range of consumption, from total 
abstinence to excessive use, have pointed to a possible non-linear association between 
alcohol use and the common mental disorders. It has been suggested that moderate levels 
of alcohol consumption are associated with a lower risk of mental health problems 
compared to total abstinence or heavy use, reflecting the analogous association of reduced 
mortality with moderate alcohol use (Ronksley et al. 2011). These findings are not 
universally accepted and have been questioned as being the result of unmeasured 
confounding factors or reverse causality (Bell and Britton, 2015; Holmes et al. 2014; Paljavri 
et al. 2009; Paschall et al. 2005; Sareen et al. 2004). Regarding the latter, the “sick-quitter” 
effect (Fillmore et al. 2007) could explain the increased prevalence of mental disorders in 
individuals abstaining from alcohol compared to moderate users (Bell and Britton, 2014), 
while the self-medication hypothesis (Bolton et al. 2009) may explain the association 
between heavy alcohol use and depression.  
The above discussion is of particular interest for patients presenting in Primary Care 
where alcohol related problems and depression are common and often co-occur with 
physical health problems. Previous longitudinal studies on the association between the 
different  levels of alcohol consumption and the common mental disorders cannot 
generalize their results in other cultures or clinical settings as they recruited community 
samples from well developed countries (Gea et al. 2013; Haynes et al. 2005; Paljavri et al. 
2009; Tait et al. 2012) and assessed depression/anxiety using self-reported diagnoses (Bell 
and Briton, 2015; Gea et al. 2013) or generic case-finding instruments (Paljavri et al. 2009; 
Tait et al. 2012) that may lack clinical validity. The available primary care studies on the 
association between different levels of alcohol consumption and depression or anxiety are 
cross sectional (Bellos et al. 2013; Kirchner et al. 2007) and cannot exclude the possibility 
of reverse causality.  
In a previous work of our research team (Bellos et al. 2013), using the cross-sectional 
baseline data from a WHO international study in primary health care, we found evidence 
for a non-linear association between the full range of alcohol use and depression or 
generalized anxiety disorder (GAD). Longitudinal data are also available from the same 
dataset in a subset of participants, who were followed-up for one year after the baseline 
assessment. Therefore, the aim of the current paper was to investigate the longitudinal 
association between different levels of alcohol consumption and a new-onset of depression 
or GAD in order to confirm whether the previously reported non-linear association is not 
the result of reverse causality. 
  
2. Material and methods 
 
2.1 General description of the data set 
The WHO collaborative study of Psychological Problems in General Health Care 
(PPGHC) investigated the prevalence and associations of common mental disorders in 15 
primary care centers from 14 countries worldwide (Ustun and Sartorius, 1995). The study 
consisted of a cross-sectional part and a one-year longitudinal extension. The 
cross-sectional part used a two-phase design. At the first phase, 25916 consecutive primary 
care attenders aged 18–65 completed the 12-item General Health Questionnaire (GHQ-12; 
Goldberg and Williams, 2000). For the second phase of the cross-sectional part, 
participants were selected using a stratified random sampling procedure according to 
site-specific GHQ-12 thresholds of the first phase (5438 out of 8698 eligible participants 
were finally assessed, 62% response rate).  
Eligible for the longitudinal part of the study were all participants with a definite or 
subthreshold psychiatric disorder at the baseline assessment as well as a 40% random 
sample of the remainder. Those were asked to complete the follow-up assessment 12 
months later. The response rate for the longitudinal assessment was 68.5% (n=3201). Data 
were collected between May 1991 and April 1992. The current paper used data from the 
longitudinal assessment only, while our previous paper (Bellos et al. 2013) used the 
cross-sectional data only.  
 
 
 
 
2.2 Measures  
2.2.1 Measurement of common mental disorders 
The primary care version of the Composite International Diagnostic Interview 
(CIDI), (Wittchen et al. 1991) was used to assess the presence of depression (F32/33) and 
generalized anxiety disorder (GAD) (F41.1). A new onset of depression or GAD was 
defined in participants who met criteria of depression or GAD at follow-up but not at 
baseline. All disorders refer to current (one-month) morbidity. 
2.2.2 Measurement of alcohol use 
Alcohol use was assessed using the WHO Alcohol Use Disorders Identification Test 
(AUDIT), a 10-item instrument which covers recent alcohol intake, dependence and 
harmful use during the previous 12 months (Saunders et al. 1993). Each question is scored 
between 0 and 4 and the total score is ranging between 0 (total abstinence) and 40.  
To take into account the possible non-linear association between alcohol use and 
mental disorders we used 6 groups of baseline alcohol use, including categories of 
abstinence or excessive drinking. The 6 groups of increasing severity were defined using 
the 25th (abstainers), 50th, 75th, 90th and 95th percentiles of total AUDIT-score as cut-offs 
for all baseline participants 
2.2.3 Assessment of other variables 
Data on possible confounders at baseline (age, sex, marital status, years of schooling, 
working status, physician's rating of current physical health, self-reported presence of 
chronic medical illness) were recorded as described in our previous publication (Bellos et 
al. 2013). 
2.3 Statistical Analysis 
Analyses were performed with STATA/SE 10.0 (STATA Corp LP, College Station, 
TX). Percentages were estimated using the “survey” commands in STATA (“svy”). 
Weights were used to take into account the stratified sampling procedure and non- 
response in follow up. The association between alcohol use at baseline and a new onset of 
depression or GAD at follow-up was assessed with a two-level logistic regression model 
(level 1: individuals, level 2: primary care centres) using the “gllamm” command in 
STATA (Rabe-Hesketh and Skrondal, 2006). Multilevel analysis accounts for any 
potential clustering of data, since participants in our study were nested into 15 centres. The 
above models were adjusted for potential confounding variables including age, sex, marital 
status, years of schooling, working status, physician's rating of current physical health and 
self-reported chronic medical diseases as well as the presence of the other mental disorder 
(e.g. GAD for model where outcome was new onset-depression and depression for models 
of new onset-GAD) For both analyses we excluded participants with depression or GAD at 
baseline and the final models included 2374 and 2676 participants for studying new-onset 
depression and GAD as outcomes, respectively. From these models we report odds ratios 
(OR) and 95% confidence intervals (CI) for the increasing levels of alcohol consumption 
using abstainers as the reference group.  
  
3. Results 
3.1 Sample characteristics - Alcohol consumption 
The 3201 primary care patients who took part at the follow-up had a mean age at 
baseline of 40.5 years (range: 18-65), while 62% were female. Comorbidity with a chronic 
medical disease was reported by 58.3% of the participants. The other baseline 
characteristics of the participants who took part in the follow-up were similar to those 
presented in our previous cross-sectional paper (Bellos et al. 2013). A new episode of 
depression (among participants without depression at baseline, N=2372) was reported by 
4.4% of the sample and a new onset of GAD (among participants without GAD at baseline, 
N=2676) was reported by 3.1% of the sample, with some cross-cultural variation.  
3.2 Association between baseline alcohol use and a new onset of Depression/GAD  
In the crude analysis, participants with “moderate” alcohol use at baseline (audit 
percentiles: 51st to 90th , total audit scores 2-8) were less likely to report a new onset of 
depression or GAD after 1 year compared to abstainers. Excessive drinking (>95th 
percentile of audit scores, total audit score >12) was associated with a higher risk for a new 
onset of depression but not for GAD. Adjustment for confounding factors (age, sex, marital 
status, working status, years of education, physician’s rating of physical health, self-rated 
presence of chronic diseases and the presence of other mental disorders in baseline) had a 
slight effect in the association between alcohol consumption and depression and the effect 
of excessive drinking became even stronger (Table 1). Regarding GAD, in the fully 
adjusted model (model 2, Table 1) the statistically significant lower risk for GAD was 
observed in upper moderate drinking (audit percentiles: 76th to 90th , audit scores: 5-8), 
although the trend was the same for the previous consumption category as well (audit 
percentiles: 51st to 75th, audit scores: 2-4). Heavy drinking (audit percentiles: 91st to 95th) 
was associated (although marginally) with a higher risk for GAD. The same trend was 
noticed in the excessive drinking category (96th – 100th percentile), but the confidence 
intervals were wide and included the null value. 
We also present the analysis separately for men and women (Table 2). Regarding 
depression, we observed the same trends as with the main analysis for both genders. 
However, for GAD there was a trend for an association between heavy / excessive alcohol 
consumption and an increased incidence of GAD in males but not in females. It should be 
noted that ORs were not statistically significant, possibly due to the limited statistical 
power. 
  
4. Discussion 
4.1 Key findings 
Our results support a non-linear association between alcohol consumption and a new 
onset of depression and generalized anxiety disorder. In particular, participants with 
moderate alcohol consumption at baseline had a lower risk for developing a new onset of 
depression or GAD at follow-up compared to participants who abstained from alcohol at 
baseline. In addition, we confirmed that excessive alcohol consumption increased the risk 
for a new onset of depression while the association of heavy/excessive alcohol use with 
GAD was more complex. These findings were largely independent of the presence of 
chronic medical illnesses or sociodemographic variables.  
  
4.2 Study findings under the light of the literature 
Several previous cross-sectional studies, including our own analysis of the baseline 
data of the same WHO study (Bellos et al. 2013), have also pointed to a possible non-linear 
association of alcohol use with common mental disorders (Caldwell et al. 2002; O’Donnell 
et al. 2006; Power et al. 1998; Skogen et al. 2009). Cross-sectional studies however cannot 
exclude alternative explanations related to temporal issues, since common mental 
disorders may lead to increased alcohol consumption [“self-medication” (Bolton et al. 
2009)] or alcohol use cessation (“sick-quitters”). The present longitudinal analysis 
confirms the results of a few other longitudinal studies on this issue (Bell and Britton, 
2015; Bell and Britton, 2014; Cougle et al. 2015; Gea et al. 2013; Gea et al. 2012; Tait et al. 
2012) that moderate alcohol consumption may reduce the risk for developing a new 
episode of depression compared to abstinence, making less likely that this is due to reverse 
causality. Moreover, considering the effect of physical health in alcohol mental health 
association our results are in partial concordance with longitudinal studies supporting a 
stronger effect (Bell and Briton, 2015) but most longitudinal studies dot not specifically 
examined confounding due to physical health (Cougle et al. 2015; Gea et al. 2012; Tait et 
al. 2012).  Compared to other longitudinal studies, the present study assessed mental 
disorders with a detailed structured psychiatric interview, used a cross-cultural sample and 
was conducted in Primary Care, making the generalisability of the results easier in clinical 
settings. 
Regarding gender differences, onset of depression showed similar trends in both 
genders (lower risk in moderate consumption, higher in excessive consumption). This is in 
concordance with previous longitudinal (Gea et al. 2012, Tait et al. 2012) and 
cross-sectional studies (Caldwell et al. 2002; Coehlo et al. 2014; Graham et al. 2007). In 
GAD there was some evidence that men may be more vulnerable than women to a new 
onset of generalized anxiety at higher levels of alcohol consumption, although this was a 
non-significant trend (table 2). As most previous longitudinal studies have focused on 
depression only (Bell and Britton, 2014; Bulloch et al. 2012; Fergusson et al. 2009; Gea et 
al. 2012; Gilman and Abraham, 2001; Tait et al. 2012) this finding cannot be confirmed, 
but it is worth noting that some cross sectional studies do not support this distinction 
(Rodgers 2000; Skogen et al. 2009). In any case our subgroup analysis by gender is limited 
in statistical power. 
The psychotropic effect of alcohol is mainly attributed to its act on GABA 
(gamma-aminobutyric acid )  receptors, leading to relaxation, negative thoughts 
suppression, sedation and disinhibition, or to the opiate-mediated reward neurotransmitter 
systems, leading to positive reinforcement of alcohol seeking and use.  These biological 
effects are further mediated by genetic variation within other types of neurotransmitter 
(serotonin) and hormonal (corticotropin-releasing factor) systems that regulate stress and 
emotions (Heilig et al., 2011, Mohler et al., 2012). Moreover, the level of response to 
alcohol and the associated risk for developing alcohol tolerance and dependence are 
associated with genetic variation in GABA and serotonin receptors (Edenberg et al., 2004, 
Schuckit et al 1999, Soyka et al., 2008). Some longitudinal studies support the 
anti-oxidative properties of red wine (Vazour, 2012) and associate moderate alcohol 
consumption with neuroprotective effects in humans (den Heijer et al., 2004, Anstey et al., 
2009) and neuroproliferation in animal models (Aberg et al., 2005) . Conclusively, a 
biological antidepressant and anxiolytic effect of moderate alcohol use cannot be excluded, 
although the exact mechanisms are largely unknown 
 
4.3 Limitations 
Our results should be considered under the following limitations: the past 
(pre-baseline) alcohol use and mental health history of the participants was unknown. 
Therefore, we cannot exclude the possibility that previous mental health problems led to 
abstinence (“sick quitter” effect) (Ng Fat and Shelton, 2012). Furthermore, the reported 
association could be explained as a result of unmeasured confounding factors such as 
personality, lifestyle and socioeconomic variables. We should like to note however that 
adjustment for several sociodemographic and physical health variables in the current study 
had a small effect in the reported associations. The length of follow-up in our study was 
relatively short (12 months) and we do not know what would happen in the longer term 
(Bell and Britton, 2015). Finally, in our subgroup analyses the statistical power was limited 
and the results should be treated with caution (type II error). 
. 
4.4 Conclusions 
Moderate daily drinking can be a slippery slope that many individuals may not be 
able to control (O'Keefe et al. 2007). It is difficult to predict what percentage of current 
moderate drinkers will face future alcohol-related problems. On the other hand, the use of 
alcohol to relieve affective symptoms is common among individuals with mood disorders, 
yet it is associated with increased psychiatric morbidity (Bolton et al. 2009). Our study 
points to a possible "protective" effect of moderate drinking in the risk of developing a new 
onset of common mental disorders. However, despite our longitudinal design, alternative 
explanations of unknown or unmeasured confounding factors cannot be excluded Causal 
inference presupposes combined and consistent evidence of a strong and “dose-response” 
association from different research sources, biological plausibility and randomized 
controlled trial evidence. Taking into account that such interventions would be unlikely or 
unethical to be conducted, evidence from observational studies using different but 
complementary methodologies (Glymour et al. 2014) could be used to conclude whether 
moderate alcohol consumption could lower the risk for common mental disorders. In any 
case, the possible beneficial effects of alcohol in mental health should be balanced against 
the elevated risks of excessive consumption for both physical and mental health (Lim et al. 
2013). 
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Tables 
 
Table 1 Association between different levels of alcohol use at baseline and new onset of Depression/GAD in an international primary 
care sample (n=3201) 
 
Generalized Linear Latent and Mixed 
Models (GLLAMM) 
Incidence at one year follow-up 
Depression 
(among participants free of depression at baseline, n=2372) 
GAD 
(among participants free of GAD at baseline, n=2676) 
percentile range of 
AUDIT SCORE  
at baseline 
 
Corresponding 
AUDIT-score  N (%) 
Crude OR 
(95% CI) 
Adjusted OR 1 †  
(95% CI) 
Adjusted OR 2 ‡ 
(95% CI) 
N (%) 
Crude OR 
(95% CI) 
Adjusted OR 1 †  
(95% CI) 
Adjusted OR 2 ‡ 
(95% CI) 
0 – 25th  0 (abstainers) 70 (5.7%) 1.0 1.0 1.0 74 (4.5%) 1.0 1.0 1.0 
26th – 50th  1 48 (4.5%) 
0.7 
(0.4 – 1.2) 
0.8 
(0.5 – 1.2) 
0.8 
(0.5 – 1.3) 
40 (2.8%) 
0.7 
(0.3 – 1.3) 
0.7 
(0.3 – 1.8) 
0.8 
(0.3 – 2.1) 
51st  - 75th  2-4 22 (2.6%) 
0.3* 
(0.1 – 0.7) 
0.4* 
(0.2 – 0.9) 
0.4* 
(0.2 – 0.9) 
26 (2.2%) 
0.5* 
(0.3 – 0.8) 
0.6 
(0.3 – 1.3) 
0.8 
(0.4 – 1.8) 
76th – 90th  5-8 21 (3%) 
0.5* 
(0.3 – 0.9) 
0.9 
(0.5 – 1.5)  
0.9 
(0.5– 1.6) 
11 (1%) 
0.2* 
(0.1 – 0.4) 
0.4* 
(0.2 – 0.8) 
0.4* 
(0.2 – 0.9) 
91st – 95th  9-12 11 (2.8%) 
0.5 
(0.2 – 1.01) 
0.7 
(0.4 – 1.4) 
0.8 
(0.4 – 1.4) 
8 (2.7%) 
0.8 
(0.4 – 1.6) 
1.4 
(0.9 – 2.2) 
1.6* 
(1.1 – 2.3) 
96th – 100th  13-34 13 (9.9%) 
2.3* 
(1.01 – 4.0) 
3.5* 
(1.6 – 7.7) 
3.2* 
(1.4 – 7.1) 
8 (4.2%) 
0.7 
(0.4 – 1.5) 
1.7 
(0.6 – 5.1) 
1.5 
(0.5 – 4.7) 
N= actual number of observations, %=weighed percentages, *=p<0.05 comparing to abstainers 
† Adjusted for age, sex, marital status, working status, years of education, 
‡ Adjusted  for all variables included in previous model  plus physician’s rating of physical health, self-rated presence of chronic diseases and baseline GAD (for incident 
depression as outcome variable) or baseline Depression (for incident GAD, respectively)  
 Table 2 Association between different levels of alcohol use at baseline and new onset of Depression/GAD in an international primary 
care sample separately for males and females  
 
Logistic Regression 
models§ 
New onset of Depression New onset of GAD 
Males Females Males Females 
percentile range of AUDIT 
SCORE  
at baseline 
 
N (%) 
OR†  
(95% CI) 
N (%) 
OR † 
(95% CI) 
N (%) 
OR†  
(95% CI) 
N (%) 
OR† 
(95% CI) 
0 – 25th  11 (2.3%) 1.0 59 (7.1%) 1.0 8 (1.7%) 1.0 66 (5.6) 1.0 
26th – 50th  15 (5.8%) 
2.1 
(0.5 – 8.9) 
33 (4%) 
0.6 
(0.4 – 1.2) 
10 (1.8%) 
2.1 
(0.4 – 12.1) 
30 (3.2%) 
0.7 
(0.4 – 1.6) 
51st  - 75th  3 (0.6%) 
0.2 
(0.1 – 1.5) 
19 (3.5%) 
0.4 
(0.1 – 1.1) 
7 (1.3%) 
1.9 
(0.3 – 12.2) 
19 (2.6%) 
0.9 
(0.4 – 2.3) 
76th – 90th  10 (1.5%) 
0.7 
(0.2 – 3.0) 
11 (6.2%) 
1.1 
(0.4 – 2.9) 
4 (0.6%) 
0.9 
(0.1 – 6.2) 
7 (1.6%) 
0.4 
(0.1 – 1.2) 
91st – 95th  9 (3.2%) 
2 
(0.6 – 7) 
2 (1.7%) 
0.2 
(0.1 – 1.3) 
7 (2.5%) 
3.8 
(0.8 – 17.9) 
1 (3.1%) 
0.8 
(0.1 – 9.4) 
96th – 100th  9 (9.3%) 
2.4 
(0.3 – 21.3) 
4 (17.2%) 
3.3 
(0.7 – 14.8) 
6 (4.1%) 
2.5 
(0.1 – 41.3) 
2 (5.5%) 
0.7 
(0.1 – 3.9) 
 
N= actual number of observations, %=weighed percentages,  
† Adjusted  for age, sex, marital status, working status, years of education, physician’s rating of physical health, self-rated presence of chronic diseases and 
baseline GAD (for incident depression as outcome variable) or baseline Depression (for incident GAD, respectively)  
§ using “svy” commands in STATA (see methods)  
